Cutting edge: Fas ligand (CD178) cytoplasmic tail is a positive regulator of Fas ligand-mediated

被引:10
|
作者
Jodo, S
Pidiyar, VJ
Xiao, S
Furusaki, A
Sharma, R
Koike, T
Ju, ST [1 ]
机构
[1] Univ Virginia, Dept Internal Med, Div Rheumatol & Immunol, Charlottesville, VA 22908 USA
[2] Hokkaido Univ, Grad Sch Med, Dept Med 2, Sapporo, Hokkaido, Japan
来源
JOURNAL OF IMMUNOLOGY | 2005年 / 174卷 / 08期
关键词
D O I
10.4049/jimmunol.174.8.4470
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The cytotoxic function of CD178 (Tas ligand (FasL)) is critical to the maintenance of peripheral tolerance and immune-mediated tissue pathology. The active site of FasL resides at the FasL extracellular region (FasL(Ext)) and it functions through binding/cross-linking Fas receptor on target cells. In this study, we report that FasL(Ext)-mediated cytotoxicity is regulated by the FasL cytoplasmic tail (Fas(LCyt)). Deleting the N-terminal 2-70 aa (Delta 70) or N-terminal 2-33 aa (Delta 33) reduced the cytotoxic strength as much as 30- to 100-fold. By contrast, change in the cytotoxic strength was not observed with FasL deleted of the proline-rich domains (45-74 aa, Delta PRD) in the FasL(Cyt) Our study identifies a no velfunction of FasL(Cyt) and demonstrates that FasL(Cyt), a sequence unique to FasL, is critically required for the optimal expression of FasL(Ext)-mediated cytotoxicity.
引用
收藏
页码:4470 / 4474
页数:5
相关论文
共 50 条
  • [41] Fas-ligand (CD178) and TRAIL synergistically induce apoptosis of CD40-activated chronic lymphocytic leukemia B cells
    Dicker, F
    Kater, AP
    Fukuda, T
    Kipps, TJ
    BLOOD, 2005, 105 (08) : 3193 - 3198
  • [42] VIP and PACAP inhibit Fas ligand-mediated bystander lysis by CD4+ T cells
    Delgado, M
    Ganea, D
    JOURNAL OF NEUROIMMUNOLOGY, 2001, 112 (1-2) : 78 - 88
  • [43] Fas/Fas ligand-mediated apoptosis of antigen-bearing Langerhans cells in draining lymph nodes.
    Kawamura, T
    Shimada, S
    Yagita, H
    Okumura, K
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 488 - 488
  • [44] Cutting edge: Chemotactic activity of soluble Fas ligand against phagocytes
    Seino, K
    Iwabuchi, K
    Kayagaki, N
    Miyata, R
    Nagaoka, I
    Matsuzawa, A
    Fukao, K
    Yagita, H
    Okumura, K
    JOURNAL OF IMMUNOLOGY, 1998, 161 (09): : 4484 - 4488
  • [45] Upregulation of Fas/Fas ligand-mediated apoptosis by gossypol in an immortalized human alveolar lung cancer cell line
    Chang, JS
    Hsu, YL
    Kuo, PL
    Chiang, LC
    Lin, CC
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2004, 31 (10): : 716 - 722
  • [46] Fas Ligand-mediated cytotoxicity of CD4+ T cells during chronic retrovirus infection
    Anna Malyshkina
    Elisabeth Littwitz-Salomon
    Kathrin Sutter
    Gennadiy Zelinskyy
    Sonja Windmann
    Simone Schimmer
    Annette Paschen
    Hendrik Streeck
    Kim J. Hasenkrug
    Ulf Dittmer
    Scientific Reports, 7
  • [47] Fas Ligand-mediated cytotoxicity of CD4+T cells during chronic retrovirus infection
    Malyshkina, Anna
    Littwitz-Salomon, Elisabeth
    Sutter, Kathrin
    Zelinskyy, Gennadiy
    Windmann, Sonja
    Schimmer, Simone
    Paschen, Annette
    Streeck, Hendrik
    Hasenkrug, Kim J.
    Dittmer, Ulf
    SCIENTIFIC REPORTS, 2017, 7
  • [48] The role of fas-fas ligand-mediated apoptosis in autoimmune lacrimal gland disease in MRL/MpJ mice
    Jabs, DA
    Lee, B
    Whittum-Hudson, J
    Prendergast, RA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (02) : 399 - 401
  • [49] Genetic polymorphisms of Fas (CD95) and Fas ligand (CD178) influence the rise in CD4+ T cell count after antiretroviral therapy in drug-naïve HIV-positive patients
    Milena Nasi
    Marcello Pinti
    Roberto Bugarini
    Leonarda Troiano
    Enrico Lugli
    Cristian Bellodi
    Cristina Mussini
    Vanni Borghi
    Tommaso Trenti
    Fiorella Balli
    Roberto Esposito
    Andrea Cossarizza
    Immunogenetics, 2005, 57 : 628 - 635
  • [50] Fas ligand-mediated bystander lysis of syngeneic cells in response to an allogeneic stimulus
    Smyth, MJ
    JOURNAL OF IMMUNOLOGY, 1997, 158 (12): : 5765 - 5772